Abstract

In patients (pts) with pulmonary hypertension (PH) different right ventricular (RV) function parameters predict outcome. Data regarding the prognostic value of averaged 6-segments RV longitudinal strain (RV-GLS) in PH pts are scarce. To assess the predictive value of 6-segments RV-GLS in PH pts receiving vasodilator therapy. Forty-seven pts (40 ± 15 years, 36 women) with PH treated with either bosentan, sildenafil, or both and 33 controls with similar age and gender (40 ± 11 years, 21 women) were studied. Clinical parameters and biologic (B-type natriuretic peptide, BNP), invasive and echocardiographic parameters of RV function (TAPSE, TDI-derived free-RV wall S- and e’-wave, RV fractional area change (FAC), Tei index, I/H, RV isovolumic acceleration-IVA) were assessed. 6-segments RV-GLS was measured from the apical 4-chamber view by STE. PH pts were followed-up for 23 months (2–49). An endpoint of cardiac death was defined. PH pts had larger right chambers size, PA size and pressures, impaired RV function than controls (all P < 0.001), including RV-GLS (−14.0 ± 4.8% vs. −23.3 ± 2.7%, P < 0.001). During follow-up, 8 pts died. At univariable analysis, predictors of death were: TAPSE (15 ± 3 mm in deceased pts vs. 18 ± 3 mm in surviving pts, P = 0.011), RV-S (9.1 ± 2.1 cm/s vs. 11.5 ± 1.9 cm/s, P = 0.002), FAC (25 ± 9% vs. 36 ± 8%, P = 0.001), RV-GLS (−9.6 ± 4.2% vs. −14.9 ± 4.5%, P = 0.003), IVA (0.16 ± 0.07 cm/s 2 vs. 0.24 ± 0.10 cm/s 2 , P = 0.041) and BNP levels (lnBNP, 5.8 ± 1.0 vs. 4.7 ± 1.5, P = 0.05). ROC curve analysis showed that RV-GLS had the highest predictive value for cardiac death (AUC 0.82, P = 0.005). Cutoff value for RV-GLS derived from ROC curve analysis was used to construct Kaplan-Meier survival curves. A value of −13.2% for RV-GLS predicted cardiac death with 87% sensitivity and 62% specificity. In PH pts, RV function parameters have prognostic value. Six-segments RV-GLS emerged as the strongest predictor of cardiac death with a cutoff value of −13.2% in this setting.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.